The distinguishing cellular features of pulmonary artery smooth muscle cells from chronic thromboembolic pulmonary hypertension patients

REFERENCES

• Lang IM, Pesavento R, Bonderman D, : Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462–468.
   Google Scholar
• Fedullo PF, Auger WR, Kerr KM, : Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345(20):1465–1472.
   Google Scholar
• Pengo V, Lensing AW, Prins MH, : Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–2264.
   Google Scholar
• Wynants M, Quarck R, Ronisz A, : Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012;40(4):886–894.
   Google Scholar
• Ogawa A, Firth AL, Yao W, : Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L666–L676. PMCID: 2770792.
   Google Scholar
• Yao W, Firth AL, Sacks RS, : Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2009;296(6):L870–L88. PMCID: 2692803.
   Google Scholar
• Sakao S, Hao H, Tanabe N, : Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells. Resp Res. 2011;12(109): doi: 10.1186/1465-9921-12-109.
   Google Scholar
• Moser KM, Braunwald NS: Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest. 1973;64(1):29–35.
   Google Scholar
• Moser KM, Bloor CM: Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685–692.
   Google Scholar
• Yi ES, Kim H, Ahn H, : Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension—a morphometric and immunohistochemical study. Am J Resp Crit Care. 2000;162(4):1577–1586.
   Google Scholar
• Berger G, Azzam ZS, Hardak E, : Idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: can we be certain? Isr Med Assoc J. 2011; 13(2):106–110.
   Google Scholar
• Valchanov K, Vuylsteke A: Pulmonary endarterectomy. Eur J Anaesthesiol. 2006;23(10):815–823.
   Google Scholar
• Roscoe A, Klein A: Pulmonary endarterectomy. Curr Opin Anaesthesiol. 2008;21(1):16–20.
   Google Scholar
• Utley JR, Spragg RG, Long WB, 3rd, et al.: Pulmonary endarterectomy for chronic thromboembolic obstruction: recent surgical experience. Surgery. 1982;92(6):1096–1102.
   Google Scholar
• Jamieson SW, Kapelanski DP, Sakakibara N, : Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–1462; discussion 62–64.
   Google Scholar
• Mayer E, Klepetko W: Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):589–593.
   Google Scholar
• Cao J, Gong L, Guo DC, : Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/− mice. Hum Mol Genet. 2010;19(10):1908–1920. PMCID: 2860890.
   Google Scholar
• Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767–801.
   Google Scholar
• Morrell NW, Yang X, Upton PD, : Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation. 2001;104(7):790–795.
   Google Scholar
• Warburg O: On the origin of cancer cells. Science. 1956;123(3191):309–314.
   Google Scholar
• Zhang S, Fantozzi I, Tigno DD, : Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2003;285(3):L740–L754.
   Google Scholar
• Maruoka M, Sakao S, Kantake M, : Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2011;159(2):119–127.
   Google Scholar
• Rai PR, Cool CD, King JA, : The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;178(6):558–564. PMCID: 2542431.
   Google Scholar
• Sakao S, Tatsumi K: Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities. Int J Cardiol. 2011;147(1): 4–12.
   Google Scholar
• Dewachter L, Adnot S, Fadel E, : Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med. 2006;174(9):1025–1033.
   Google Scholar
• Eddahibi S, Guignabert C, Barlier-Mur AM, : Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation. 2006;113(15):1857–1864.
   Google Scholar
• Quarck R, Wynants M, Ronisz A, : Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients. Respir Res. 2012;13:27. PMCID: 3352254.
   Google Scholar
• Holley RW: Control of growth of mammalian cells in cell culture. Nature. 1975;258(5535):487–490.
   Google Scholar
• Madden MC, Vender RL, Friedman M: Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins. 1986;31(6):1049–1062.
   Google Scholar
• Dawes KE, Peacock AJ, Gray AJ, : Characterization of fibroblast mitogens and chemoattractants produced by endothelial cells exposed to hypoxia. Am J Respir Cell Mol Biol. 1994;10(5):552–559.
   Google Scholar
• Marsboom G, Archer SL: Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells. Circ Res. 2008;103(10):1047–1049. PMCID: 2853810.
   Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. PMCID: 2849637.
   Google Scholar
• Bustamante E, Pedersen PL: High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA. 1977;74(9):3735–3739. PMCID: 431708.
   Google Scholar
• Bustamante E, Morris HP, Pedersen PL: Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem. 1981;256(16):8699–8704.
   Google Scholar
• Mathupala SP, Ko YH, Pedersen PL: Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006;25(34):4777–4786.
   Google Scholar
• Masri FA, Xu W, Comhair SA, : Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L548–L554.
   Google Scholar
• Li S, Tabar SS, Malec V, : NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal. 2008;10(10):1687–1698.
   Google Scholar